Paul Quinlan - Jun 30, 2023 Form 4 Insider Report for CymaBay Therapeutics, Inc. (CBAY)

Role
General Counsel
Signature
/s/ Paul Quinlan
Stock symbol
CBAY
Transactions as of
Jun 30, 2023
Transactions value $
-$35,550
Form type
4
Date filed
6/30/2023, 04:51 PM
Previous filing
May 17, 2023
Next filing
Jul 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBAY Common Stock Options Exercise $14.7K +5K $2.94* 5K Jun 30, 2023 Direct
transaction CBAY Common Stock Sale -$50.3K -5K -100% $10.05 0 Jun 30, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBAY Employee Stock Option (right to buy) Options Exercise $0 -5K -2.56% $0.00 190K Jun 30, 2023 Common Stock 5K $2.94 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into on February 14, 2023.
F2 The option grant vests as to 1/48 of the underlying shares monthly from January 1, 2022.